GlycoMimetics Inc (NAS:GLYC)
$ 0.39 -0.02 (-4.88%) Market Cap: 25.15 Mil Enterprise Value: 4.50 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 30/100

Q3 2022 GlycoMimetics Inc Earnings Call Transcript

Nov 09, 2022 / 01:30PM GMT
Release Date Price: $0.8202 (+19.32%)
Operator

Good morning, and thank you for joining the GlycoMimetics' Q3 2022 Earnings Call. (Operator Instructions)

I would now like to turn the call over to Christian Dinneen-Long, the Company Counsel at GlycoMimetics. Please go ahead.

Christian Dinneen;Long
GlycoMimetics, Inc. - VP, Corporate Counsel & Corporate Secretary

Good morning. Today, we will review our business updates and financial results for the quarter ended September 30, 2022. The press release we issued this morning is available on the company's website at glycomimetics.com under the Investors tab. This call is being recorded. A dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available for 30 days in the Investor Relations section of the company's website.

Joining me on the call today from GlycoMimetics are Harout Semerjian, Chief Executive Officer; Brian Hahn, Chief Financial Officer; Dr. Ed Rock, Chief Medical Officer; and Bruce Johnson, our Chief Commercial Officer.

We will start today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot